Skip to main content
Vistin Pharma logo

Vistin Pharma — Investor Relations & Filings

Ticker · VISTN ISIN · NO0010734122 LEI · 5967007LIEEXZXFQY092 OL Manufacturing
Open in API
Filings indexed 519 across all filing types
Latest filing 2022-04-28 AGM Information
Country NO Norway
Listing OL VISTN

About Vistin Pharma

https://www.vistin.com/

Vistin Pharma is a pharmaceutical company specializing in the production of Metformin Hydrochloride, an Active Pharmaceutical Ingredient (API). The company operates as a pure-play, global supplier, providing high-quality Metformin to pharmaceutical companies worldwide. In addition to the standard API, Vistin Pharma offers specialized grades such as Direct Compressible (DC) Metformin. With over 50 years of experience, the company emphasizes sustainable manufacturing from its dedicated European production facility.

Recent filings

Filing Released Lang Actions
Vistin Pharma ASA: Notice of Annual General Meeting
AGM Information Classification · 98% confidence The document explicitly states it is a "Proposal from the Election Committee in Vistin Pharma ASA for the Annual General Meeting to be held in May 2022." It details proposals regarding the election of Board members and the Election Committee, as well as proposed remuneration for these bodies. This content directly relates to the agenda and materials presented or prepared for the Annual General Meeting (AGM). Therefore, the most appropriate classification is AGM Information (AGM-R).
2022-04-28 Norwegian
Vistin Pharma ASA: Notice of Annual General Meeting
Remuneration Information Classification · 99% confidence The document is explicitly titled 'Independent auditor's assurance report on remuneration report'. It contains an 'Opinion' from the auditors (Ernst & Young AS) regarding the preparation of the company's 'report on salary and other remuneration to directors (the remuneration report)' for the financial year ended 31 December 2021. This content directly relates to executive compensation disclosure, which aligns with the definition for Remuneration Information (DEF 14A). Although it is an audit report *on* the remuneration report, the core subject matter is remuneration disclosure, making DEF 14A the most specific fit among the provided options, as AR (Audit Report/Information) is generally for standalone financial audits or stress tests, whereas this is specific to remuneration.
2022-04-28 Norwegian
Vistin Pharma ASA: Notice of Annual General Meeting
Remuneration Information Classification · 99% confidence The document is explicitly titled "Remuneration report for salary and other remuneration for leading persons 2021". It contains detailed sections on the remuneration of the Board of Directors and Executive Management, including fixed salaries, bonuses (STIP), pension plans, and comparisons to previous years. This content directly aligns with the definition of a Remuneration Information report, which corresponds to the DEF 14A filing type in the provided schema, although the document itself is a standalone remuneration report rather than a definitive proxy statement (DEF 14A). Given the specific focus on executive and board compensation, DEF 14A is the most appropriate classification among the choices, as it covers compensation details. It is a full report, not just an announcement (RPA).
2022-04-28 Norwegian
Vistin Pharma ASA: Notice of Annual General Meeting
Remuneration Information Classification · 98% confidence The document is explicitly titled "Statement regarding the determination of salary and other remuneration to Executive Management" and details the principles, decision-making process, and components (fixed salary, bonus, pension, LTIP) for compensating the Board of Directors and Executive Management. This content directly aligns with the definition of a Remuneration Information document, which corresponds to the DEF 14A filing type in the provided schema, even though the document itself is a policy statement rather than a final report of compensation paid (which would typically follow this policy). Given the options, DEF 14A (Remuneration Information) is the most specific fit for a document detailing executive compensation policy and structure.
2022-04-28 Norwegian
Vistin Pharma ASA: Notice of Annual General Meeting
Annual Report Classification · 100% confidence The document is titled 'Directors' report for 2021' and contains comprehensive financial results, operational performance, management discussion, and corporate social responsibility disclosures for the full fiscal year 2021. It includes detailed financial statements, balance sheet data, and management's analysis of the business. This aligns with the definition of an Annual Report (10-K) as it covers company activity and full financial performance for the year. FY 2021
2022-04-28 Norwegian
Vistin Pharma ASA: Notice of Annual General Meeting
AGM Information Classification · 100% confidence The document text explicitly contains the phrase "INNKALLING TIL ORDINÆR GENERALFORSAMLING I VISTIN PHARMA ASA" (Calling Notice for Annual General Meeting in Vistin Pharma ASA). This clearly indicates the document is a notice or invitation for the Annual General Meeting (AGM). The definition for AGM-R covers "Presentations and materials shared during the Annual General Meeting (AGM)". While this is the *notice* for the meeting, in the context of standard corporate filings, the notice itself is intrinsically linked to the AGM event materials. It is not a proxy statement (PSI) as it is the initial call, nor is it a DVA (which reports the results). Therefore, AGM-R is the most appropriate classification.
2022-04-28 Norwegian

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.